Show simple item record

dc.contributor.authorFrýbortová, Veronika
dc.contributor.authorŠatka, Štefan
dc.contributor.authorJourová, Lenka
dc.contributor.authorZapletalová, Iveta
dc.contributor.authorŠrejber, Martin
dc.contributor.authorBriolotti, Philippe
dc.contributor.authorDaujat-Chavanieu, Martine
dc.contributor.authorGerbal-Chaloin, Sabine
dc.contributor.authorAnzenbacher, Pavel
dc.contributor.authorOtyepka, Michal
dc.contributor.authorAnzenbacherová, Eva
dc.date.accessioned2024-11-18T10:58:28Z
dc.date.available2024-11-18T10:58:28Z
dc.date.issued2024
dc.identifier.citationInternational Journal of Molecular Sciences. 2024, vol. 25, issue 7, art. no. 3610.cs
dc.identifier.issn1661-6596
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10084/155312
dc.description.abstractAs compounds of natural origin enter human body, it is necessary to investigate their possible interactions with the metabolism of drugs and xenobiotics in general, namely with the cytochrome P450 (CYP) system. Phytic acid (myo-inositol hexaphosphoric acid, IP6) is mainly present in plants but is also an endogenous compound present in mammalian cells and tissues. It has been shown to exhibit protective effect in many pathological conditions. For this paper, its interaction with CYPs was studied using human liver microsomes, primary human hepatocytes, the HepG2 cell line, and molecular docking. Docking experiments and absorption spectra demonstrated the weak ability of IP6 to interact in the heme active site of CYP1A. Molecular docking suggested that IP6 preferentially binds to the protein surface, whereas binding to the active site of CYP1A2 was found to be less probable. Subsequently, we investigated the ability of IP6 to modulate the metabolism of xenobiotics for both the mRNA expression and enzymatic activity of CYP1A enzymes. Our findings revealed that IP6 can slightly modulate the mRNA levels and enzyme activity of CYP1A. However, thanks to the relatively weak interactions of IP6 with CYPs, the chances of the mechanisms of clinically important drug-drug interactions involving IP6 are low.cs
dc.language.isoencs
dc.publisherMDPIcs
dc.relation.ispartofseriesInternational Journal of Molecular Sciencescs
dc.relation.urihttps://doi.org/10.3390/ijms25073610cs
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution.cs
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/cs
dc.subjectphytic acidcs
dc.subjectIP6cs
dc.subjectphytatescs
dc.subjectcytochrome P450cs
dc.subjectCYP1Acs
dc.subjectdrug metabolismcs
dc.titleOn the possible effect of phytic acid (myo-inositol hexaphosphoric acid, IP6) on cytochromes P450 and systems of xenobiotic metabolism in different hepatic modelscs
dc.typearticlecs
dc.identifier.doi10.3390/ijms25073610
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume25cs
dc.description.issue7cs
dc.description.firstpageart. no. 3610cs
dc.identifier.wos001201042000001


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution.
Except where otherwise noted, this item's license is described as © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution.